A sleep-mood intervention improves insomnia symptoms in university students but has little impact on their mental health and quality of life.

Insomnia is a sleep disorder in which you have trouble falling asleep, staying asleep, or waking up too early. The condition can be short term (acute) or can last a long time (chronic). It may ...

The luxury hotel brand partnered with Dr. Matthew Walker to launch a Sleep Lab, blending science and luxury to transform how ...

including 12 randomised clinical trials, which NICE said provide "good quality evidence" that the app can improve sleep in people with self-reported insomnia symptoms. It has recommended a medical ...

Lemon myrtle oil has long been used by Australia’s Indigenous community for wound care and healing. Now, scientists in ...

Use the diaphragm, the large breathing muscle the middle of our torso. This means breath movements are notable in the abdomen ...

New research highlights concerns about sleep aids disrupting the brain's cleaning process and their long-term effects on ...

By establishing coding and separate payment for certain digital mental health devices, this group from CMS and the FDA hopes ...

For people with anxiety and depression, these conditions can feel like two sides of the same coin. Researchers are exploring ...

Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces an oral ...

Nexalin Technology (NXL) providing an update on the Company’s technology advancements, clinical achievements, and strategic focus for 2025.

Eisai has launched its insomnia drug Dayvigo in Japan, the second in a new class of medicines after Merck & Co’s Belsomra, which made its debut there in 2014. Dayvigo (lemborexant) is a dual ...